Drug-Development Challenges for Small Biopharmaceutical Companies.
From the Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD (R.A.M.); and Sanofi Genzyme, Cambridge, MA (P.K.T.).
Richard A
RA
Moscicki
From the Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD (R.A.M.); and Sanofi Genzyme, Cambridge, MA (P.K.T.).
P K
PK
Tandon
D015415:Biomarkers / Q000032:analysis; D002986:Clinical Trials as Topic / Q000191:economics / Q000592:standards*; D003132:Commerce; D055808:Drug Discovery; D004345:Drug Industry; D005819:Genetic Markers; D065386:Historically Controlled Study; D006801:Humans; D053208:Kaplan-Meier Estimate; D015990:Placebo Effect
D015415:Biomarkers; D005819:Genetic Markers